Active Filters
- 2022Clear filter
Nov 23, 2022
Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens
Nov 21, 2022
SWOG researchers will present 10 abstracts at SABCS 2022. Here are highlights.
Nov 18, 2022
Nov 11, 2022
This Veterans Day, we announce our first VA storefront award
Nov 8, 2022
With a long lead time, SWOG has begun the search for its next group chair
Nov 4, 2022
Nov 3, 2022
Adding stratification factors can reduce a small trial’s statistical power